Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precis... Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.313 | -76.7156862745 | 0.408 | 0.4096 | 0.0832 | 24335996 | 0.11051699 | CS |
4 | -0.4352 | -82.0822331196 | 0.5302 | 0.5905 | 0.0832 | 6838240 | 0.15221474 | CS |
12 | -0.445 | -82.4074074074 | 0.54 | 0.65 | 0.0832 | 3000099 | 0.23556557 | CS |
26 | -0.6495 | -87.239758227 | 0.7445 | 1.56 | 0.0832 | 2164944 | 0.42013535 | CS |
52 | -1.255 | -92.962962963 | 1.35 | 2.57 | 0.0832 | 1566368 | 0.67514769 | CS |
156 | -3.605 | -97.4324324324 | 3.7 | 5.85 | 0.0832 | 686120 | 1.13083455 | CS |
260 | -3.125 | -97.049689441 | 3.22 | 7.72 | 0.0832 | 531220 | 1.95825087 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales